Pacific Biosciences Of California (PACB) Construction in Progress (2016)
Pacific Biosciences Of California (PACB) posted quarterly Construction in Progress of $5.8 million for Q4 2016.
Pacific Biosciences Of California (PACB) Construction in Progress (2016) Analysis & Trends
Pacific Biosciences Of California's Construction in Progress history runs 1 years deep, the most recent figure standing at $5.8 million for Q4 2016.
- In Q4 2016, Construction in Progress changed N/A year-over-year to $5.8 million; the TTM figure through Dec 2016 stood at $5.8 million (changed N/A YoY), while the FY2016 annual figure was $5.8 million, changed N/A from the prior year.
- Construction in Progress for Q4 2016 stood at $5.8 million.
- The five-year high for Construction in Progress was $5.8 million in Q4 2016, with the low at $5.8 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 911.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | - |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 455.10 Mn |
| 10 | Pacific Biosciences Of California | 397.95 Mn | 161.08 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 5.80 Mn |